Atlas Trials

Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRI

Clinical trial NCT03749252 · COMPLETED

Trial details

NCT number
NCT03749252
Sponsor
Guerbet
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Central Nervous System IndicationPediatric PatientsBody Indication
Start date
2018-11-06
Primary completion
2019-12-18
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.